Why the US‑Canada Trade War Could Change How American Farmers Grow Their Crops for Years

 

Why the US‑Canada Trade War Could Change How American Farmers Grow Their Crops for Years

## A Broken Alliance, A Bitter Harvest

For generations, the world's longest undefended border has been a symbol of trust and shared prosperity. American and Canadian farmers have operated as partners, not adversaries, moving livestock, machinery, and grain across the 49th parallel with a handshake and a promise.

That era ended on a sweltering Saturday in August 2026.

When trade talks between the United States and Canada collapsed on August 22, President Donald Trump made good on his threat, slapping **50% tariffs** on a sweeping range of Canadian imports worth roughly **$20 billion (CAD $27 billion)**. The list was broad and punitive: dairy, alcohol, appliances, clothing, furniture, steel, aluminum — and a slew of agricultural products that had moved freely across the border for decades.

Canada didn't blink. Prime Minister Mark Carney announced a **dollar‑for‑dollar** retaliation, with counter-tariffs of **15%, 25%, and 50%** on over 700 U.S. products, set to take effect September 8. The Canadian list targeted American steel, dairy, appliances, agricultural equipment, pulp and paper, electronics, seafood, and more. "Canada will match the United States tariffs dollar for dollar, rate for rate," declared Finance Minister François-Philippe Champagne.

The message was unmistakable: **the longest undefended border in the world had become a front line.**

For American farmers, already battered by soaring fertilizer costs, drought, and the economic fallout of the Iran war, this was a disaster they didn't see coming — and one they may not survive.

---

## The Fertilizer Crisis: When Potash Becomes Politics

### The 85% Dependency

Here's the number that should keep every American farmer awake at night: **85%**.

That's the share of potash — a critical fertilizer ingredient — that U.S. farmers import from Canada. Without it, yields drop. Crops fail. The food supply chain fractures.

Potash is a potassium-rich mineral mined primarily in Saskatchewan, where the soil holds the world's largest reserves. It's essential for plant growth, helping crops resist drought, disease, and nutrient deficiency. For corn, soybeans, wheat, and virtually every major American commodity crop, potash is not optional.

Saskatchewan Premier Scott Moe, whose province will soon supply **half of the world's potash**, has fiercely rejected any suggestion of export levies on the mineral. "What we, as a province, cannot and will not support is any kind of export tariff on our natural resources," he said. His reasoning was blunt: taxing potash exports would backfire by costing Canadian jobs and pushing U.S. buyers toward other suppliers — likely Belarus.

But the threat remains. If pushed too far, Canada could levy export tariffs on potash, raising prices for U.S. buyers and squeezing already-thin farm margins. As one analysis put it, "There is an unspoken threat that it could expand to a crucial component in fertilizer that U.S. farmers rely on".

### Nitrogen: The Iran War Connection

The potash threat comes on top of another crisis. When the U.S. and Israeli war with Iran shut down shipping through the Strait of Hormuz, it cut off a large source of nitrogen fertilizer, sending prices soaring. Nitrogen, which washes out of soil and must be reapplied every year, is the backbone of modern agriculture. Without it, yields plummet.

The combined effect has been devastating. A Farm Bureau survey in April 2026 found that **70% of farmers said they couldn't afford all the fertilizer they needed during spring planting**. Fertilizer costs have jumped about **40% this year**. And with the trade war adding uncertainty to potash supplies, farmers are facing a choice: **cut back on fertilizer and accept smaller harvests, or take on more debt and pray for better prices.**

### A Slow-Motion Crisis

The effects won't be visible overnight. A farmer who reduces fertilizer use by 10% this year might not notice the difference until the combine rolls through the field in autumn — and the yield monitor shows a 10-bushel-per-acre shortfall. But across thousands of farms, those small reductions add up.

**Smaller harvests lead to higher food prices.** Higher food prices lead to tighter household budgets. Tighter budgets lead to less spending. And less spending slows the entire economy.

All because a fertilizer ingredient became a bargaining chip.

---

## The Machinery Trap: When Parts Cross the Border 11 Times

### The Integrated Supply Chain

American farmers don't just buy equipment. They buy *systems* — tractors, combines, planters, and sprayers assembled from components that crisscross the border multiple times before reaching the dealership.

"Farm equipment is assembled from parts that cross the border. Live cattle and processed foods also move both ways," explains agricultural researcher Dr. Rodney B. Holcomb. "Tariffs can raise costs along that chain."

When the U.S. imposes a 50% tariff on Canadian steel and aluminum, it doesn't just hurt Canadian mills. It raises the cost of every piece of equipment that contains those metals — which is to say, virtually every piece of equipment on a modern farm.

Canada's retaliatory tariffs on agricultural equipment will hit American manufacturers directly. For farmers in border states like Minnesota — which exports about **$5.5 billion in goods to Canada each year** — the impact is immediate and personal.

### The Squeeze

Gary Wertish, president of the Minnesota Farmers Union, puts it bluntly: "It's putting downward pressure on our prices that we are able to sell the products for. So we're getting squeezed on both ends."

He's not exaggerating. In Minnesota, creditors are required by state law to enter a mediation period with a farm owner before foreclosure. Wertish said **more Minnesota farmers have entered that mediation process this year than in the last three years combined** — a trend he attributes, at least partly, to tariff impacts.

"If the U.S. doesn't change its trade policies," warns Jacob Walker, an international trade consultant, "the likelihood that Minnesota has built up the infrastructure to withstand the gap left from Canadian exports, it's unlikely. It's going to hurt."

### A Perfect Storm

For farmers like Lynwood Broaddus, who grows corn and soybeans in Caroline County, Virginia, the trade war is just one piece of a much larger puzzle. "This year has been basically the perfect storm of things. Mother Nature, economic conditions on both supply sides, but then also on the prices that we do receive [for produce]," said Scott Sink, president of the Virginia Farm Bureau Federation.

Drought, spring freezes, skyrocketing gas prices, and now tariffs — all hitting at once. "Diesel fuel is going to be something that's going to hurt," Broaddus said. "But we have to get that crop in one way or another."

---

## The Long Game: How Trade Policy Reshapes Farming

### The 2018 Precedent

History offers a grim preview. When China retaliated against Trump's first-term tariffs in 2018, it targeted U.S. soybeans and automobiles. American agricultural exports to China **fell by $7 billion to $10 billion a year** as Chinese buyers shifted to Brazilian suppliers.

The lesson was brutal: **trade flows reorganize faster than farmers can adapt.** When North American trade barriers go up, U.S. imports of fruits and vegetables from Canada and Mexico typically drop, with buyers turning to Australia and Argentina instead. The result is often higher consumer prices for key agricultural products in the United States.

### Will History Repeat?

Canada is one of the largest markets for American food, importing about **$28 billion** in U.S. agricultural products in 2025. Both countries are deeply integrated in agricultural trade and farm equipment markets. If Canadian buyers shift to other suppliers — or if American farmers lose access to Canadian markets — the damage could be years in the making.

As one analyst put it, "When North American trade barriers go up, U.S. imports of fruits and vegetables from Canada and Mexico typically drop, with buyers turning to Australia and Argentina instead."

### A New Crop of Decisions

The enduring effect of this trade war, if it continues to escalate, won't be a single bad season. It will be a series of hard choices:

- Which crops to plant — and which to abandon

- How much fertilizer to apply — and how much yield to sacrifice

- Whether to invest in new equipment — or make do with aging machinery

- Whether to expand — or to get out

Across thousands of farms, these decisions will add up. Some farmers will switch to less fertilizer-intensive crops. Others will reduce acreage. A few will walk away entirely.

**The American agricultural landscape, shaped by decades of free trade, is about to be remade by tariffs.**

---

## The Human Toll: 'Remember the Little Guy'

### Virginia's Warning

Senator Tim Kaine (D‑Va.) sat down with Virginia farmers in late August to hear their concerns. Canada is Virginia's largest export market. In 2025, **$2.9 billion in goods** were exported to Canada, representing 15% of the state's total goods exports.

The farmers didn't hold back. "Commodity prices have been sort of flat," Kaine said. "All the input prices are going up, export markets are shutting down. You really worry about the ability of families to stay in."

When asked what he would say to those negotiating the tariff deals, Broaddus offered a plea: "Remember the little guy" — including himself and other farmers who eventually bear the brunt of rising costs that are then passed on to consumers.

### Minnesota's Mediation Crisis

In Minnesota, the numbers are even more stark. "It's almost like the weather forecast. It changes day to day," said Gary Wertish. But the trend is clear: more farmers are entering foreclosure mediation than in the last three years combined.

For the families behind those farms, the trade war isn't an abstraction. It's the difference between passing the farm to the next generation and watching it be auctioned off to the highest bidder.

### The Dairy Divide

Not everyone is opposed to the tariffs. The National Milk Producers Federation thanked the Trump administration for continuing to pressure Canada over what it calls unfair dairy trade practices.

"We appreciate the Administration's persistence in standing up for American dairy producers and exporters who have waited far too long for Canada to live up to its promises," said Krysta Harden, president and CEO of U.S. Dairy Export Council.

But even dairy farmers may find that the cure is worse than the disease. Canada's retaliatory tariffs will hit American dairy exports hard, and the broader economic disruption could reduce demand for all agricultural products.

---

## The Lessons of History

### The 2018 Tariff Hangover

The Trump administration's first trade war with China offers a sobering preview. Research shows U.S. agricultural exports to China **fell by $7 billion to $10 billion a year** — a loss that took years to partially recover.

When North American trade barriers go up, the pattern is similar. U.S. imports of fruits and vegetables from Canada and Mexico typically drop, with buyers turning to other suppliers. The result is often higher consumer prices for key agricultural products in the United States.

### A Different Kind of Fight

This time, the stakes are different. The U.S. is fighting a trade war with its largest agricultural trading partner — a country that supplies 85% of its potash, shares integrated supply chains, and has a leader who has promised to match tariffs "dollar for dollar."

Carney's message to Trump was blunt: "Canada will match the United States tariffs dollar for dollar, rate for rate." And he means it.

---

## What Comes Next

### The September Deadline

Canada's retaliatory tariffs take effect September 8. For American farmers, that's the day when the costs of the trade war become real — and permanent.

If the tariffs remain in place for years, as some analysts expect, the damage could be long-lasting. Farmers may have to reduce fertilizer use, switch to less profitable crops, or exit the industry entirely.

### The Potash Wild Card

The biggest unknown is whether Canada will eventually impose export tariffs on potash. Saskatchewan Premier Scott Moe has rejected the idea, but the pressure from other provinces may grow as the trade war drags on.

If potash exports are taxed, American fertilizer prices could skyrocket — and with them, the cost of producing food.

### A Chance for Diplomacy

Not everyone has given up on a resolution. Agriculture Secretary Brooke Rollins acknowledged that farmers and ranchers are worried about the trade war, but she defended Trump's negotiating tactics. The administration is "working closely with ranchers to grow America's cattle-herd size, which is currently at a multi-decade low."

But for farmers facing foreclosure, "working closely" isn't enough. They need relief — and they need it now.

---

## Frequently Asked Questions

### 1. Why is potash so important to American farmers?

Potash is a potassium-rich mineral used in fertilizer to help crops grow. It's essential for plant health, drought resistance, and yield. The U.S. imports about **85% of its potash from Canada**. Without it, crop yields would drop significantly.

### 2. How will the trade war affect fertilizer prices?

Fertilizer prices are already high due to the Iran war, which disrupted nitrogen supplies. If Canada imposes export tariffs on potash, prices could rise even further. A Farm Bureau survey found **70% of farmers couldn't afford all the fertilizer they needed** during spring planting.

### 3. Will American farmers switch to other suppliers?

Canada is the world's largest potash exporter. Other suppliers like Belarus exist, but switching would take time and increase costs. Saskatchewan Premier Scott Moe warned that taxing potash exports would push U.S. buyers toward other suppliers.

### 4. How will the tariffs affect farm equipment?

Farm equipment is assembled from parts that cross the border multiple times. Tariffs on steel, aluminum, and finished equipment will raise costs for American farmers, squeezing already thin margins.

### 5. What crops will be most affected?

Commodity crops like corn, soybeans, and wheat are highly fertilizer-dependent. If fertilizer prices rise, farmers may switch to less fertilizer-intensive crops or reduce acreage.

### 6. Will consumers see higher food prices?

Yes. Reduced fertilizer use leads to smaller harvests, which leads to higher food prices. As one analysis put it, "The lasting impact could emerge later in smaller future harvests".

### 7. How are farmers coping?

Many are taking on more debt, cutting costs, or considering exit. In Minnesota, **more farmers have entered foreclosure mediation this year than in the last three years combined**. Virginia farmers are calling on policymakers to "remember the little guy".

### 8. Can the trade war be resolved?

Both sides have signaled they're open to negotiations, but no talks are currently scheduled. U.S. Trade Representative Jamieson Greer said there are no "open channels" of communication.

---

## A Harvest of Consequences

The U.S.-Canada trade war is not just another political fight. It is a fundamental threat to the way American farmers grow their crops — and to the food supply that sustains the nation.

The numbers are stark: 85% of potash from Canada. A 40% increase in fertilizer costs. A 70% of farmers who can't afford what they need. Thousands of farms in foreclosure mediation.

The effects of this trade war, if it continues to escalate, will not be a single bad season. They will be a slow, grinding erosion of American agricultural capacity — smaller harvests, higher food prices, and fewer family farms.

For farmers like Lynwood Broaddus, the message is simple: "Remember the little guy." The little guy who grows the food, who feeds the nation, who has been caught in the crossfire of a trade war he never asked for.

The tariffs took effect on August 22. Canada's retaliation begins September 8. And for American farmers, the harvest of consequences has only just begun.

Vanguard Pays $4.6B for RIA Software Startup Altruist

Vanguard Pays $4.6B for RIA Software Startup Altruist

## The $4.6 Billion Bet That Changes Everything

On Wednesday, August 26, 2026, Vanguard Group—the $12 trillion asset management giant built on the foundation of low-cost index funds—did something that would have been unthinkable just a few years ago. It agreed to acquire Altruist, a California-based fintech startup that provides software and custody services for independent registered investment advisors (RIAs).

The price tag: **$4.6 billion** in an all-cash deal. That's more than double Altruist's $1.9 billion valuation from its Series F funding round in early 2025. And it signals a fundamental shift in how the world's second-largest investment firm views its future.

For a company that practically invented the low-cost investing revolution, this acquisition represents a dramatic pivot: Vanguard is no longer content to just manage money. It wants to control the technology that powers the entire financial advisory industry.

---

## The Numbers That Matter

| Metric | Detail |

|--------|--------|

| **Deal Value** | $4.6 billion (all-cash) |

| **Altruist's Last Valuation** | $1.9 billion (April 2025) |

| **Total VC Raised** | Over $600 million |

| **Vanguard's AUM** | $12 trillion |

| **Deal Structure** | All-cash; Altruist to operate as standalone |

| **Expected Close** | Late 2026, subject to regulatory approval |

The deal was initiated by Vanguard, not Altruist. The startup wasn't looking for a buyer. But Vanguard CEO Salim Ramji saw something that made the $4.6 billion price tag worth every penny.

---

## Why Vanguard Is Betting Big on Advice

### The Ramji Doctrine

Salim Ramji took the helm at Vanguard in 2024 and immediately began reshaping the firm's strategy. He established a new advice and wealth management division and made it clear that Vanguard would look beyond its core business of low-fee stock-and-bond funds.

The Altruist acquisition is the culmination of that vision.

"Many investors in Vanguard funds choose to work with financial advisors, and far more people could benefit from access to financial advice than the industry can serve today," Ramji said in a statement. "The need is broad, but the capacity to provide high-quality advice is limited. Technology can help close that gap".

Ramji framed the deal as a natural extension of Vanguard's mission: "Altruist's mission to make financial advice more accessible, more affordable, and help advisers scale their practices, that very much rhymes with what we're trying to do here at Vanguard".

### The $10 Trillion Opportunity

The RIA market is massive—and growing. It serves tens of millions of clients with north of **$10 trillion in assets**. Demand for financial planning and investment management has ballooned in recent years, driven by a robust stock market rally that has increased the net worth of wealthy Americans.

High-touch financial advice has traditionally been reserved for individuals with millions in investible assets. But Vanguard is aiming to expand that universe with lower-cost options. Altruist's technology is designed to help advisors scale their practices and serve more clients efficiently.

---

## What Altruist Actually Does

### The Modern RIA Custodian

Altruist, founded in 2018 by Jason Wenk, is an upstart competitor to Charles Schwab and Fidelity Investments in providing custodial and administrative work to independent financial advisers. It operates a **self-clearing brokerage** along with software for opening accounts, portfolio management, billing, and reporting.

The platform is purpose-built for RIAs, offering:

- **Integrated custody and clearing**

- **Account opening and transfers**

- **Fractional share trading**

- **Automated rebalancing**

- **Billing and performance reporting**

- **Mobile-first onboarding** with instant account validation

- **High-yield cash management**

Altruist has also made waves with its **Hazel AI tax tool**, which can create personal tax strategies by interpreting financial documents without any manual entry. When Hazel was announced in February 2026, it sent shares of Charles Schwab, Raymond James, and other financial-services providers sharply lower.

"We've had the benefit of getting to get to know Altruist's people, platform, and potential over the last several years," Ramji said, noting that Vanguard first invested in Altruist in 2020.

---

## The Strategic Rationale: Why This Deal Makes Sense

### 1. Vertical Integration

Vanguard has long been a leader in asset management. But it has never had direct control over the technology and custody infrastructure that powers the advisory industry. By acquiring Altruist, Vanguard brings that capability in-house.

Vanguard itself will become an anchor client for parts of the platform, Ramji said. That gives Altruist a guaranteed source of scale and revenue, while giving Vanguard direct access to Altruist's innovative technology.

### 2. The AI Frontier

Altruist's Hazel AI tool has already demonstrated the power of AI to disrupt the financial advisory industry. By acquiring Altruist, Vanguard gains control of that technology—and the talent behind it.

"We see a significant opportunity to build on the strengths of two highly complementary organizations to help advisors serve clients more effectively," Ramji said.

### 3. The "Vanguard Effect"

Vanguard has long been known for the "Vanguard effect"—the pressure it puts on the entire industry to lower fees. By bringing Altruist into the fold, Vanguard can extend that effect to the technology and custody space.

Altruist's transparent fee model includes no commissions on equities or ETFs and no unexpected account maintenance fees. That aligns perfectly with Vanguard's low-cost ethos.

### 4. Competition with Schwab and Fidelity

The deal puts Vanguard in direct competition with Charles Schwab and Fidelity in the RIA custody market. Both firms have dominated this space for years. Altruist's technology-driven approach offers a differentiated alternative.

As one analyst put it, the acquisition could "turn up the heat on Schwab".

---

## How the Deal Will Work

### Standalone Structure

Following the close of the transaction, Altruist is expected to operate as a **standalone business**, retaining its leadership, brand, advisor focus, and distinct operating model under Vanguard's ownership.

This structure is intentional. It preserves the speed, entrepreneurial culture, and proximity to advisors that have shaped Altruist's growth, while giving the company greater resources to invest and innovate.

Altruist CEO and founder Jason Wenk will remain in place. "Altruist was built on the simple belief that when independent advisors have better technology and lower prices, they can do their best work and bring high-quality advice to more people," Wenk said.

### What Vanguard Gets

Vanguard will benefit from:

- **Closer relationships** with independent advisors and their clients

- **Direct access** to Altruist's innovative technology and advisor platform

- **A foothold** in the fast-growing RIA custody market

- **AI capabilities** that can be integrated across its business

### The Expected Timeline

The transaction is expected to close **later in 2026**, subject to customary closing conditions, including receipt of required regulatory approvals.

---

## The Market Reaction

### Altruist's Trajectory

Altruist had raised over **$600 million** in venture capital funding, most recently at a $1.9 billion post-money valuation in early 2025. The $4.6 billion acquisition price represents a premium of more than 140% over that valuation.

The company had been growing rapidly, with its platform serving thousands of independent advisors. But it wasn't seeking a buyer. Vanguard initiated the process.

### The Industry Impact

The deal is already reshaping the RIA custody market. Schwab and Fidelity now face a well-capitalized competitor backed by the world's second-largest investment firm.

The acquisition also highlights the growing importance of technology in the advisory space. As Jason Wenk noted, the RIA market has long consisted of "many disconnected technology systems that don't speak well with each other". Altruist was built to solve that problem.

---

## What This Means for Advisors and Investors

### For Advisors

Altruist's platform will continue to operate as before, but with greater resources and backing. Advisors can expect:

- **More investment** in technology and custody capabilities

- **Access to Vanguard's scale** and investment expertise

- **Continued focus** on advisor needs and client outcomes

"We look forward to building the future of Altruist together," Wenk said.

### For Investors

The deal could ultimately benefit investors through:

- **Lower costs** for financial advice

- **Better technology** enabling advisors to serve more clients effectively

- **Greater competition** in the RIA custody market

As Ramji put it: "Technology can help close that gap by enabling advisors to serve more people and serve them better, while preserving the human judgment and relationships at the center of good financial advice".

---

## Frequently Asked Questions (FAQs)

### 1. How much did Vanguard pay for Altruist?

Vanguard paid **$4.6 billion** in an all-cash deal. Some reports initially estimated the deal at around $4 billion, but Axios confirmed the $4.6 billion figure.

### 2. Who is Altruist?

Altruist is a California-based fintech company founded in 2018 that provides software and custody services for independent registered investment advisors (RIAs). It operates a self-clearing brokerage along with software for account opening, portfolio management, billing, and reporting.

### 3. Why is Vanguard buying Altruist?

Vanguard is seeking to expand into financial advice and compete with firms like Schwab and Fidelity in the RIA custody market. The acquisition gives Vanguard direct access to Altruist's technology, advisor relationships, and AI capabilities.

### 4. Will Altruist continue to operate independently?

Yes. Altruist is expected to operate as a **standalone business**, retaining its leadership, brand, advisor focus, and distinct operating model under Vanguard's ownership.

### 5. What is the Hazel AI tool?

Hazel is Altruist's AI-powered tax planning tool that can create personal tax strategies by interpreting financial documents without any manual entry. When it was announced in February 2026, it sent shares of Schwab, Raymond James, and other financial-services providers sharply lower.

### 6. When will the deal close?

The transaction is expected to close **later in 2026**, subject to customary closing conditions, including receipt of required regulatory approvals.

### 7. What does this mean for advisors who use Altruist?

Advisors can expect continued investment in Altruist's technology and custody capabilities, along with access to Vanguard's scale and investment expertise.

### 8. Was Altruist looking to be acquired?

No. Vanguard initiated the process. Altruist wasn't seeking a buyer.

---

## The Bottom Line

Vanguard's $4.6 billion acquisition of Altruist is one of the most significant deals in the history of financial services technology. It represents a fundamental shift in strategy for the world's second-largest investment firm—a move away from pure asset management and toward vertical integration of the entire advisory value chain.

The deal brings together Vanguard's $12 trillion in assets, its reputation for low costs, and its commitment to investor outcomes with Altruist's modern technology platform, AI capabilities, and growing network of independent advisors.

For Vanguard CEO Salim Ramji, the acquisition is the centerpiece of his vision to expand the firm's reach beyond index funds and into the fast-growing wealth management space. For Altruist founder Jason Wenk, it's validation of a vision he's been building since 2018.

And for the millions of Americans who work with financial advisors—or who could benefit from doing so—it's a sign that the future of financial advice is about to become more accessible, more affordable, and more technologically advanced.

As Ramji put it: "Technology can help close that gap by enabling advisors to serve more people and serve them better". With this acquisition, Vanguard is betting billions that he's right.

---

## Disclaimer

*This article is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. All views expressed are based on publicly available information as of August 27, 2026. The acquisition described is subject to regulatory approvals and other customary closing conditions and may not be completed as described. The author does not endorse any specific investment strategies or products. Before making any investment decisions based on the content of this article, please consult with qualified professionals who can evaluate your specific situation.*

The Day the Sun Came to the Desert

 The Day the Sun Came to the Desert

## Groundbreaking held for nuclear fusion facility in New Mexico

**Pacific Fusion breaks ground on $1 billion 'Demonstration System' designed to produce more energy than it consumes by 2030—a milestone that has never before been achieved.**

On a sun-scorched Tuesday morning in Albuquerque's Mesa del Sol community, a crowd of policymakers, scientists, and investors gathered not just to break ground on another industrial facility, but to witness what they believe could be the beginning of the end of the fossil fuel era.

California-based startup Pacific Fusion officially broke ground on a $1 billion Research & Manufacturing Campus, a project designed to achieve two first-ever milestones: **net facility gain**—producing more energy from fusion than the total energy initially stored in the machine—and **high-yield fusion**, a critical capability for U.S. national security.

"Rarely do we have a chance to invest in a foundational technology," said Albuquerque Mayor Tim Keller at the ceremony. "Something that has the potential to be transformative, something that we could be known for not just across the country, but around the world."

---

## The Promise of 'Net Facility Gain'

For decades, the fundamental question surrounding fusion energy has been one of sustainability: can it produce more energy than it consumes? In 2022, researchers at Lawrence Livermore National Laboratory achieved **ignition**—they got more energy out of the fuel than went into the fuel. That was a scientific breakthrough. But it was not enough.

Pacific Fusion's Demonstration System aims to go further. **Net facility gain** means the machine produces more fusion energy than the **total energy initially stored in the system**—accounting for all the energy lost during power conversion and system operations. It is a milestone that has never before been demonstrated and represents a key stepping stone on the path to commercial fusion power.

The company's ultimate target: achieve net facility gain by **2030**.

"We're not building an incremental improvement change," said Pacific Fusion CEO Keith LeChien. "This is a major step change, and a major step forward for the country."

---

## The Technology: Pulsed Magnetic Fusion

Pacific Fusion is pursuing a path that sets it apart from other fusion efforts. Unlike groups focused on tokamaks (like ITER) or massive lasers (like the National Ignition Facility), Pacific Fusion is developing a **pulsed magnetic** approach to inertial confinement fusion.

The technology uses intense, precisely synchronized electrical pulses to magnetically compress and heat deuterium-tritium fuel targets. The company's "brick-based" pulsed power architecture replaces one massive, expensive machine with many small, mass-producible modules—called "bricks"—that deliver the massive electrical currents needed to compress fusion fuel.

The new 225,000-square-foot campus will house a 156-module pulser array designed to emit fusion bursts exceeding **100 megajoules**—roughly ten times greater than the output of the National Ignition Facility.

That output makes it the **only "high-yield" fusion facility under construction in the United States**.

---

## National Security: A 'Long-Sought Platform'

The facility's mission extends beyond clean energy. High-yield fusion refers to the capability to create certain conditions relevant to national security research, providing a long-sought platform for the science required to maintain the U.S. nuclear stockpile **without explosive nuclear testing**.

The U.S. government first identified the need for this capability more than 30 years ago. At the groundbreaking ceremony, the Department of Energy's National Nuclear Security Administration (NNSA) and Pacific Fusion announced a public-private partnership—a Memorandum of Understanding to collaborate on high-yield fusion, high-energy-density science, pulsed-power technologies, advanced materials, and modeling.

The partnership underscores the fusion facility's dual importance: it's not just about powering the grid, but about maintaining America's strategic advantage.

---

## The Race with China

Former Google CEO Eric Schmidt, who attended the groundbreaking, told attendees he believes the U.S. is in a race with China when it comes to fusion energy research. China is investing billions in next-generation fusion for both energy and national security, attempting to beat America in a field that U.S. national labs made possible.

Pacific Fusion's privately funded, U.S.-built fusion facility is designed to keep America ahead.

"America pioneered the breakthroughs that brought fusion within reach," said Keith LeChien. "Pacific Fusion is focused on converting that scientific leadership into industrial capability and infrastructure that strengthens U.S. energy leadership and national security. Today's groundbreaking shows that America can still build the hard things, and build them faster than any other country, including China."

Carrie von Muench, COO and co-founder of Pacific Fusion, added: "The country that figures out how to manufacture and deploy these systems at scale will create an entirely new energy industry around them. We want that industry, its supply chains, and its jobs to be built here in America."

---

## Why New Mexico?

The decision to build in Albuquerque was not accidental. It was heavily driven by the region's existing **applied physics workforce**, largely tied to nearby Sandia National Laboratories with its Z Pulsed Power Facility—the world's most powerful pulsed-power facility.

Pacific Fusion's approach builds directly on decades of research at Sandia's **Z Machine**, which uses electrical currents and magnetic fields to produce high temperatures and X-rays.

"New Mexico is where Pacific Fusion will build the system designed to prove that practical fusion power is possible," said Keith LeChien. "The state brings together scientific and engineering talent, a deep legacy in pulsed-power research and leaders who understand the urgency of building. This campus will be the foundation for our fusion system and, we hope, for a much larger fusion energy ecosystem here in New Mexico."

The state's proximity to Sandia and Los Alamos national laboratories, specialized scientific workforce, advanced-manufacturing base, and ability to move major projects forward quickly were central to the company's decision.

---

## Economic Impact: Jobs and Investment

The project is expected to create **more than 200 permanent jobs**, along with hundreds of construction and regional supply-chain jobs. The company has already hired **more than 70 people** at a manufacturing facility in Los Lunas—95% of them from New Mexico—where components for the demonstration facility are being built.

The state and city secured $10 million in Local Economic Development Act funds for the expansion, and the state committed nearly $4 million through the Job Training Incentive Program. The company was also awarded $776.6 million in industrial revenue bonds, granting tax exemptions for 20 years.

Gov. Michelle Lujan Grisham called the groundbreaking a major milestone in New Mexico's drive to become a national hub for advanced, carbon-free energy.

"Less than a year ago, we announced that Pacific Fusion had selected New Mexico for this extraordinary investment, and today, construction begins," Lujan Grisham said. "Pacific Fusion's decision to build here demonstrates that New Mexico leads the nation in creating the industries of the future. This facility will create high-quality jobs, strengthen our advanced-manufacturing economy and help establish New Mexico as the place where the next-generation energy is developed and ultimately deployed."

---

## Fusion's Safety Profile

One of the most compelling arguments for fusion energy is its safety profile. Unlike nuclear fission, which powers today's nuclear plants and produces long-lived radioactive waste, fusion produces no such waste and carries no risk of meltdown.

"There's no uranium, no plutonium; the fuel is water basically," said Carrie von Muench, Pacific Fusion's COO. "We have a safety profile that looks a lot more like a hospital or a particle accelerator."

Fusion has the potential to provide abundant, carbon-free energy that isn't weather dependent, without the risk of meltdown or long-lived radioactive waste.

---

## The Challenge Ahead: 'How Do We Manufacture This?'

While the scientific breakthrough of ignition has been achieved, the challenge has now shifted from physics to engineering.

"It's no longer 'How do we make this work scientifically? It's 'How do we get the fuel to that pressure?'," von Muench said.

Pacific Fusion's next major technical milestone is the demonstration of a **full-scale pulser module**, which will serve as the core building block for its fusion system. If successful, the company will move from proving the science to demonstrating that fusion can be manufactured at scale—a transition that could define the next decade of American energy policy.

---

## Frequently Asked Questions (FAQs)

### 1. What is Pacific Fusion?

Pacific Fusion is a California-based startup founded in 2023 that is developing a pulsed magnetic fusion system using modular, mass-manufacturable components made of readily available materials. The company emerged from stealth mode in October 2024, announcing a $900 million Series A funding commitment led by General Catalyst.

### 2. What is the facility in New Mexico?

The facility is a $1 billion Research & Manufacturing Campus at Mesa del Sol in Albuquerque. It will house Pacific Fusion's Demonstration System, designed to achieve net facility gain by 2030—producing more energy from fusion than the total energy initially stored in the machine.

### 3. When will the facility be operational?

Pacific Fusion estimates the facility will be up and running and able to produce more energy than it uses by **2030**.

### 4. What is "net facility gain"?

Net facility gain means the fusion machine produces more energy than the total energy initially stored in the system—accounting for all energy lost during power conversion and operations. It has never been demonstrated before.

### 5. How many jobs will the facility create?

The project is expected to create **more than 200 permanent jobs**, along with hundreds of construction and regional supply-chain jobs. The company already employs more than 70 people at a manufacturing facility in Los Lunas.

### 6. How is fusion different from nuclear fission?

Fusion works similarly to how the sun works—using intense heat energy to merge the nuclei of two atoms into one, emitting energy in the process. Unlike fission, which produces long-lived radioactive waste, fusion produces no such waste and carries no risk of meltdown.

### 7. Is this a public or private project?

Pacific Fusion is a **privately funded** company, but it has signed a Memorandum of Understanding with the Department of Energy's National Nuclear Security Administration (NNSA) to collaborate on high-yield fusion and related technical areas.

### 8. Why New Mexico?

The decision was driven by the region's existing applied physics workforce, largely tied to nearby Sandia National Laboratories and its Z Pulsed Power Facility. The state's proximity to national labs, specialized workforce, and ability to move projects forward quickly were central to the decision.

---

## Conclusion: A Desert That Might Just Power the World

The groundbreaking at Mesa del Sol is not the beginning of a story—it is the middle of one. The scientific breakthroughs that made this moment possible happened years ago, in government labs funded by taxpayer dollars. The engineering challenges that remain are immense. The timeline to 2030 is ambitious, perhaps even audacious.

But what happened on Tuesday in the New Mexico desert was a declaration: America is still in the business of building the hard things. The country that pioneered the atomic age, that put a man on the moon, that developed the internet, is now trying to harness the power of the stars themselves.

U.S. Sen. Martin Heinrich (D-N.M.), who spoke at the groundbreaking, put it this way: "As big as our challenges are, the pace of solutions is going to allow us to meet and exceed those challenges. You are living in the most scientifically exciting time in the history of planet Earth."

The sun has been burning for 4.6 billion years, powered by fusion. If Pacific Fusion succeeds, humanity may finally learn how to bottle that fire. And it will have started in a patch of desert outside Albuquerque, where a handful of engineers and scientists broke ground on a machine designed to do what no machine has ever done before.

The groundbreaking is complete. The countdown to 2030 has begun.

---

## Disclaimer

*This article is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. All views expressed are based on publicly available information as of August 27, 2026. Fusion technology, construction timelines, and project milestones are subject to change. The author does not endorse any specific investment strategies or products. Before making any decisions based on the content of this article, please consult with qualified professionals who can evaluate your specific situation.*

The 'SaaSpocalypse' That Wasn't: How Salesforce Just Proved the AI Naysayers Wrong

 

The 'SaaSpocalypse' That Wasn't: How Salesforce Just Proved the AI Naysayers Wrong

**CRM stock surges 18% after an 80% earnings beat, a $2.6 billion Anthropic windfall, and Agentforce AI revenue that tripled to $1.5 billion.**

Just a few months ago, the narrative around enterprise software was dire. The rise of generative AI, skeptics argued, would commoditize traditional software, erode pricing power, and render legacy platforms obsolete. Salesforce, the $168 billion cloud giant, was repeatedly cited as ground zero for this so-called "SaaSpocalypse."

On Wednesday, August 26, 2026, CEO Marc Benioff and his team delivered a devastating rebuttal.

Salesforce didn't just beat Wall Street's expectations—it demolished them. The company reported adjusted earnings per share of **$5.90**, crushing the consensus estimate of just **$3.27**—an astonishing **80% beat**. Revenue climbed 11% year-over-year to a record **$11.35 billion**, slightly above the $11.32 billion forecast.

The stock exploded. Salesforce shares surged more than 12% in after-hours trading on Wednesday, and by Thursday's opening bell, the stock had climbed as much as **18%** in early trading. Since July, the stock has now gained nearly **50%**.

This wasn't just a beat. It was a statement. Here's how Salesforce pulled it off.

---

## The Anthropic Windfall: A $2.6 Billion Gift That Keeps on Giving

Perhaps the most eye-popping number in the report was the **$2.6 billion gain on strategic investments**. The source? Salesforce's increasingly valuable stake in Anthropic, the AI startup that is now valued at a staggering **$965 billion**.

Salesforce began investing in Anthropic in early 2023, initially putting in about **$50 million**. The company doubled down during every subsequent funding round, including Anthropic's Series G financing in February 2026. Today, that stake is worth roughly **$5 billion**—a 100x return on its initial investment.

This wasn't just a one-time accounting gain. Alphabet and Microsoft have also flagged similar gains from their Anthropic stakes in recent weeks. But for Salesforce, the timing couldn't have been better. The $2.6 billion gain helped propel net income to **$3.53 billion**, an **87% jump** from $1.89 billion a year earlier.

---

## Agentforce: The AI Engine That's Running at 240% Speed

The Anthropic windfall was a nice bonus, but the real story is Salesforce's own AI business. The company's Agentforce platform—which enables enterprises to deploy AI agents that handle tasks previously performed by humans—is accelerating at a pace that would make even Nvidia's growth rates look modest.

**Agentforce annualized revenue topped $1.5 billion, up 240% year-over-year**. The growth rate actually *accelerated* from the previous quarter, when it was over 200%.

Combined with Data 360 (which includes the Informatica Cloud business), Salesforce's AI and data products now generate nearly **$3.9 billion in annual recurring revenue**, more than tripling year-over-year.

The most dramatic indicator of AI adoption came from **Agentic Work Units (AWUs)**—a measure of discrete tasks accomplished by AI agents. These surged **97% quarter-over-quarter to 3.2 billion**. Salesforce has now delivered **7 billion AWUs** for live customer agents all-time.

Perhaps most importantly, management emphasized that AI usage is expanding rather than cannibalizing existing business. Weekly calls to Salesforce's Model Context Protocol server increased **six-fold** during the quarter, while traditional human application usage remained strong.

---

## The Financial Engine: Profitability, Cash Flow, and Margin Expansion

Beyond the AI headlines, Salesforce delivered a masterclass in operational execution.

**Free cash flow spiked 81% year-over-year to $1.1 billion**, well above the $643 million consensus. Trailing twelve-month free cash flow reached an impressive **$15.2 billion**.

The company's non-GAAP operating margin held steady at **34.1%** with GAAP operating margin at **20.5%**. Current remaining performance obligation (CRPO)—a forward-looking measure of future contracted revenue—grew **14% to $33.5 billion**. This marked the first CRPO beat in three quarters, signaling that the company's sales momentum is accelerating.

CEO Marc Benioff framed the quarter as a validation of Salesforce's transformation into what he called an **"agentic enterprise"**. Customers, he argued, want packaged software and trusted data, not just standalone AI models.

"We are no longer a CRM company," Benioff might as well have said. "We are an AI company that happens to do CRM."

---

## The Software Sector's AI Reckoning

Salesforce's blowout quarter comes at a pivotal moment for the enterprise software industry. For months, investors have debated whether AI tools like ChatGPT and Claude would displace traditional software platforms or enhance them.

The debate had real consequences. Salesforce stock was down **22.4% year-to-date** heading into the report, even as the S&P 500 rallied. Investors worried that AI would commoditize the company's core CRM offerings.

Wednesday's results suggest those fears were overblown. Salesforce didn't just survive the AI revolution—it's thriving in it. The company is embedding AI deeply into its products, and customers are paying more for the privilege.

Moreover, the company announced a new plugin called **Claudeforce**, which integrates Anthropic's Claude AI model directly into Salesforce workflows. The plugin can compose emails on behalf of salespeople, arm them with information, and update records through chat. It's a powerful example of how Salesforce is leveraging its Anthropic partnership to deepen its product moat.

---

## Guidance: The Future Looks Even Brighter

Management didn't just beat the quarter—they raised the bar for the rest of the year.

**For the fiscal third quarter**, Salesforce expects:

- Adjusted EPS: $3.42 to $3.44, above the $3.38 consensus

- Revenue: $11.42 billion to $11.50 billion, above the $11.41 billion consensus

**For the full fiscal year**, the company now sees:

- Revenue: $46.1 billion to $46.4 billion, up from $45.9 billion to $46.2 billion previously

- Adjusted EPS: $16.67 to $16.71, up from $14.06 to $14.12 previously—an **18.5% increase at the midpoint**

These are not modest tweaks. This is a company that is increasingly confident in its AI-driven growth trajectory.

---

## The Valuation Opportunity

Despite the post-earnings surge, Salesforce still looks remarkably cheap.

The stock trades at just **14.2x forward earnings**. That's inexpensive for an enterprise software company growing revenue at 11% with AI revenue tripling year-over-year. Wedbush estimates a fair value of **$310.79** per share, implying roughly **37% upside** from the post-earnings level.

The margin expansion story is equally compelling. Gross margins moved from 75.5% to 77.7%, while net margins nearly doubled from 11.9% to 18.0%. That's operating leverage in action—revenue growth flowing disproportionately to the bottom line.

Technically, the stock is in the sweet spot. The daily RSI sits at 62.6—strong enough to confirm momentum, but far from the 70+ overbought territory that would suggest exhaustion. The weekly RSI just broke above 50, signaling a fresh trend change.

---

## Frequently Asked Questions (FAQs)

### 1. How much did Salesforce beat earnings by?

Salesforce reported adjusted earnings per share of **$5.90**, compared to the consensus estimate of just **$3.27**—an **80% beat**.

### 2. What drove the $2.6 billion gain?

The $2.6 billion gain came from Salesforce's strategic investment in Anthropic, the AI startup. Salesforce's stake in Anthropic is now worth approximately **$5 billion**.

### 3. How fast is Salesforce's AI business growing?

Agentforce AI annualized revenue reached **$1.5 billion**, up **240% year-over-year**. Combined AI and data products now generate nearly **$3.9 billion in annual recurring revenue**.

### 4. What is Claudeforce?

Claudeforce is a new plugin that integrates Anthropic's Claude AI model into Salesforce workflows. It can compose emails, arm salespeople with information, and update records through chat.

### 5. What is Salesforce's guidance for the rest of the year?

Salesforce raised full-year revenue guidance to **$46.1 billion to $46.4 billion** and full-year EPS guidance to **$16.67 to $16.71**. The EPS guidance represents an 18.5% increase at the midpoint.

### 6. Is Salesforce stock still a good value after the surge?

Wedbush estimates a fair value of **$310.79**, implying roughly **37% upside** from the post-earnings level. The stock trades at just 14.2x forward earnings.

### 7. What is Agentic Work Units (AWUs)?

AWUs measure discrete tasks accomplished by AI agents. They surged **97% quarter-over-quarter to 3.2 billion**. Salesforce has delivered **7 billion AWUs** for live customer agents all-time.

### 8. How does this compare to Microsoft and ServiceNow?

Salesforce's Agentforce growth rate of 240% compares favorably to Microsoft's Copilot adoption and ServiceNow's AI workflow expansion. All three are proving that AI can drive sustainable revenue growth in enterprise software.

---

## The Bottom Line: The SaaSpocalypse Has Been Cancelled

For months, the narrative around Salesforce was one of existential threat. AI, the skeptics argued, would render traditional software platforms obsolete. Customers would bypass Salesforce and go straight to the models. The 22% year-to-date decline in the stock before earnings seemed to validate that thesis.

Wednesday's results proved otherwise. Salesforce didn't just survive the AI revolution—it's leading it. Agentforce revenue tripled to $1.5 billion. The Anthropic investment generated a $2.6 billion windfall. Free cash flow jumped 81%. And the company raised guidance across the board.

The "SaaSpocalypse" that never materialized has been replaced by something far more interesting: a software giant that is using AI to deepen its moat, expand its margins, and accelerate its growth.

As Benioff might put it: the reports of Salesforce's death were greatly exaggerated.

---

## Disclaimer

*This article is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. All views expressed are based on publicly available information as of August 27, 2026. Earnings estimates, stock prices, and market conditions are subject to change. The author does not endorse any specific investment strategies or products. Past performance is not indicative of future results. Before making any investment decisions based on the content of this article, please consult with qualified professionals who can evaluate your specific situation.*

As States Tighten Oversight, Private Equity’s Healthcare Deals Decline

 

As States Tighten Oversight, Private Equity’s Healthcare Deals Decline

## The Era of Unchecked Growth Is Over

For years, private equity firms moved through the healthcare system like a quiet tide, sweeping up physician practices, outpatient clinics, and hospitals with little public notice or regulatory friction. The strategy was simple: consolidate, cut costs, boost revenues, and exit with a hefty profit. From 2018 to 2024, the healthcare services sector averaged **903 deals per year**. In 2021 alone, private equity firms completed a staggering **851 deals** for physician practice management companies.

Those days are over.

New data from PitchBook paints a picture of a market in retreat. Private equity healthcare services deals dropped **18.5% year-over-year in the second quarter of 2026**. Total deal value for the first half of 2026 was down **7.3%**. And the segment hardest hit—physician practice management—is on track to see **half the number of deals** this year as it did in 2025.

The cause? A cascade of new state laws designed to do exactly what they're doing: slow the private equity machine down.

---

## The Numbers Tell a Stark Story

### A Market in Retreat

The data from PitchBook's Q2 2026 Healthcare Services Report is unambiguous:

**Overall Decline:** Healthcare services PE deals fell **18.5%** year-over-year in Q2 2026. The projected deal count for 2026 is on pace to be the lowest since **2017**.

**Physician Practice Management (PPM):** This segment, where private equity has the largest role, posted **71 deals** in Q2 2026, down from 111 in Q2 2025—a **35.8%** decline. The segment is on track to drop **46%** for the full year compared to 2025.

**Generalist and Multispecialty Providers:** This segment is pacing to finish 2026 at **54.4% below** 2025 levels—the steepest projected decline among all segments.

**Deal Value:** The first half of 2026 saw just **$17.8 billion** in deal value, far below the annual average of $62.8 billion since 2018.

**Exits:** 2026 exit count is projected to finish **26.5% below** 2025 levels, with exit value down **30.9%**.

### The Peak and the Fall

To understand the magnitude of the shift, consider the trajectory of physician practice management deals:

| Year | PPM Deals |

|------|-----------|

| 2021 (Peak) | 851 |

| H1 2026 | 105 |

That's a decline of nearly **88%** from the peak. What was once a gold rush has become a trickle.

---

## Why the Decline? The States Strike Back

### A Wave of New Legislation

The primary driver of the slowdown, according to PitchBook analysts, is a **slew of new state laws** targeting private equity in healthcare.

At least **11 states** have enacted laws over the past two years to increase oversight of private equity healthcare transactions:

- **California, Connecticut, Delaware, Illinois, Indiana, Maine, Massachusetts, New Mexico, Oregon, Vermont, and Washington** have all adopted measures ranging from greater disclosure and transaction review to restrictions designed to keep medical practice decisions in physicians' hands.

An additional **22 bills** are pending in state legislatures, though many have seen little recent activity. At least **26 states introduced 79 bills** in 2026 addressing private equity's role in healthcare.

### What the Laws Actually Do

The new regulations vary by state but share common themes:

**1. Advance Notice and Transparency.** A new California law that took effect January 1, 2026, requires **at least 90 days' advance notice**, as well as detailed financial and governance information for certain healthcare transactions. Rhode Island enacted a similar law requiring advance notice for transactions involving private equity firms and management services organizations.

**2. Restrictions on Corporate Control.** Oregon's law, which took effect in January 2026, prohibits management services organizations from having majority control or ownership over a medical practice. It specifically targets the "friendly physician" model, where out-of-state physicians are used to own the clinical side of a practice while investors retain control of administrative and billing services.

**3. Broader Scrutiny.** Illinois became the latest state to tighten oversight when Governor JB Pritzker signed House Bill 5000 into law on August 7, 2026, effective January 1, 2027. Connecticut passed what may be the strongest law in the country addressing transparency and accountability for private equity-owned nursing homes.

### The Practical Impact

These new regulations are having a tangible effect on dealmaking. According to PitchBook, the laws are:

- **Lengthening transaction timelines**

- **Increasing deal costs and complexity**

- **Making serial roll-up strategies more complicated to execute**

As Brian Wright, lead research analyst of healthcare at PitchBook, told Fierce Healthcare: *"That has had an impact from our conversations with several lawyers who focus on PE and healthcare services. It's a longer regulatory process, and no one wants to be the first to go through a new regulatory process"*.

---

## The Catalyst: High-Profile Failures and Public Outcry

### The Steward Health Care Collapse

The push for regulation didn't emerge from nowhere. It was fueled by high-profile failures that made private equity's role in healthcare a public issue.

The collapse of **Steward Health Care** is perhaps the most notable example. A private equity firm acquired a struggling six-hospital Massachusetts system and formed Steward in 2010. The firm later ended its investment. Steward expanded to more than 30 hospitals across eight states and entered into a sale-leaseback of hospital property with a real estate investment trust (REIT). In 2024, Steward filed for Chapter 11 bankruptcy with about **$9 billion in liabilities**, including $6.6 billion in long-term rent obligations.

### The Real Estate Trap

The Steward case highlighted a broader concern: **sale-leaseback deals** that leave hospitals without ownership of their real estate while still paying considerable rent to REITs. A 2025 study published in *The BMJ* found that among 87 hospitals whose real estate was acquired by REITs, **25% later closed or filed for bankruptcy**, compared with just 4% of matched hospitals.

These statistics have alarmed state officials and lawmakers, who are now trying to prevent similar outcomes.

### The Optum Backlash

In Oregon, the takeover of the Eugene-Springfield-area Oregon Medical Group by Optum prompted the loss of dozens of doctors who were forced to sign agreements blocking them from working for other area medical practices. Optum reversed course after pressure from lawmakers in May 2024, and Oregon's subsequent law rendered such agreements largely unenforceable.

Courtni Dresser, vice president of government relations for the Oregon Medical Association, captured the sentiment: *"We'll keep watching how it plays out in practice, but our focus remains the same: making sure physicians, not investors, are the ones making medical decisions"*.

---

## The Economic Factors: It's Not Just Regulation

While state laws are a primary driver, they're not the only factor. The slowdown in private equity healthcare deals also reflects broader economic pressures.

### Higher Interest Rates

Rising interest rate expectations have made leveraged buyouts more expensive and less attractive. The cost of debt has increased, squeezing the returns that private equity firms can generate from healthcare acquisitions.

### Soft Healthcare Utilization

Softer patient volumes have also weighed on dealmaking. Hospitals, traditionally the largest strategic acquirers of physician practices, can't proceed with deals if their bottom line has taken a hit due to lower utilization trends.

Wright speculated that lower utilization may be due to shrunk coverage for Americans who had relied on now-expired Affordable Care Act subsidies.

### The "Fear Factor"

There's also a psychological element. As one attorney cited in the PitchBook report noted, *"no one wants to be the first to go through a new regulatory process"*. The uncertainty surrounding new laws has created a wait-and-see attitude among private equity firms.

---

## The Segments: Winners and Losers

Not all healthcare segments are suffering equally. The slowdown is uneven, with some areas proving more resilient than others.

### The Hardest Hit: Physician Practice Management

PPMs have been hit hardest, with deals on track to decline by **46%** this year. The segment posted **71 deals in Q2 2026**, down from 111 in Q2 2025.

### The Steepest Decline: Generalist and Multispecialty Providers

This segment is pacing to finish 2026 at **54.4% below** 2025 levels—the steepest projected decline among all segments.

### The Most Resilient: Ancillary and Outsourced Services

Ancillary and outsourced services companies are faring best, on track to land just **4.9% below** 2025's deal count. Within this segment, clinical staffing, diagnostic labs, and ambulatory care services all remained strong.

### Bright Spots

Within other segments, urgent and emergency care, elder care, and fertility deals were bright spots. The largest transaction in the quarter was KKR's **$3.4 billion IPO** of Global Medical Response.

---

## The Human Cost: Why This Matters

Behind the numbers and regulations are real people: patients, physicians, and communities affected by private equity's presence in healthcare.

### The Patient Impact

Rhode Island Attorney General Peter Neronha framed the issue in stark terms: *"Private equity and increasing market consolidation drive up the cost of care, further inhibiting patient access"*. His state's new regulation, he said, would give his office *"a bird's eye view to ensure that future medical group mergers do not harm Rhode Islanders' access to health care services"*.

### The Physician Impact

The Optum case in Oregon illustrated how private equity takeovers can affect physicians—forcing them to sign non-compete agreements that block them from working elsewhere. Oregon's subsequent law rendered such agreements largely unenforceable.

### The Community Impact

When hospitals backed by private equity fail, communities lose access to essential healthcare services. The Steward Health Care bankruptcy left hospitals across eight states in limbo, with patients and communities bearing the consequences.

---

## The Future: What Comes Next?

### Will the Slowdown Continue?

The decline in private equity healthcare deals appears likely to continue, at least in the near term. New laws in Illinois and other states are set to take effect in 2027, adding to the regulatory burden. And the broader economic headwinds—higher interest rates, soft utilization—show no signs of abating.

### Will Private Equity Adapt?

PitchBook expects a rebound to be "imminent," but the recovery may look different from the boom years. Wright believes PPMs will benefit from efficiency gains thanks to artificial intelligence, which could eventually revive dealmaking.

But the era of unchecked consolidation is over. Future deals will likely be smaller, more targeted, and subject to greater scrutiny.

### The Policy Debate Continues

The battle over private equity in healthcare is far from settled. With at least 22 bills still pending and more states considering legislation, the regulatory landscape will continue to evolve.

As Michael Fenne, healthcare senior policy coordinator at the Private Equity Stakeholder Project, noted: *"Many [of the laws] add notice provisions that only took effect in 2026 or will take effect in 2027. It may still be too early to say"*.

---

## Frequently Asked Questions (FAQs)

### 1. How much have private equity healthcare deals declined in 2026?

Private equity healthcare services deals dropped **18.5%** year-over-year in the second quarter of 2026. Physician practice management deals are on track to decline by **46%** for the full year.

### 2. Why are private equity healthcare deals declining?

The decline is driven by a combination of factors: new state laws increasing oversight of healthcare transactions, higher interest rates, soft healthcare utilization, and uncertainty about the regulatory process.

### 3. Which states have enacted new laws targeting private equity in healthcare?

At least **11 states** have enacted laws over the past two years: California, Connecticut, Delaware, Illinois, Indiana, Maine, Massachusetts, New Mexico, Oregon, Vermont, and Washington.

### 4. What do the new state laws actually do?

The laws vary but generally require advance notice and transparency for healthcare transactions, restrict corporate control of medical practices, and increase scrutiny of private equity-owned facilities.

### 5. What is the "friendly physician" model?

The "friendly physician" model is a practice where out-of-state physicians are used to own the clinical side of a practice while investors retain control of administrative and billing services. Oregon's new law specifically targets this model.

### 6. What role did high-profile failures play in the regulatory push?

The collapse of Steward Health Care and other private equity-backed healthcare failures helped put the issue on lawmakers' radar. A study found that 25% of hospitals whose real estate was acquired by REITs later closed or filed for bankruptcy.

### 7. Will the decline in private equity healthcare deals continue?

Most analysts expect the slowdown to continue in the near term, as new laws take effect and economic headwinds persist. However, PitchBook expects a rebound to be "imminent," potentially driven by efficiency gains from artificial intelligence.

### 8. What does this mean for patients?

Proponents of the new regulations argue that increased oversight will protect patients from the negative effects of consolidation, including higher costs and reduced access to care.

---

## Conclusion: A Pivotal Moment for Healthcare

The decline in private equity healthcare deals marks a pivotal moment in the ongoing debate over the role of investors in America's healthcare system. After years of rapid consolidation, the brakes are finally being applied.

The new state laws reflect a growing recognition that healthcare is not like other industries. When private equity firms treat hospitals and physician practices as assets to be bought, stripped, and sold, patients suffer, physicians leave, and communities lose access to essential care.

The Steward Health Care collapse, the Optum backlash, and the mounting evidence of harm have prompted a regulatory response that is reshaping the healthcare M&A landscape. Deals are taking longer, costing more, and facing greater scrutiny.

Whether this slowdown represents a permanent shift or a temporary pause remains to be seen. PitchBook expects a rebound, driven by the promise of AI-driven efficiency gains. But the era of unchecked consolidation is over.

As Oregon Medical Association's Courtni Dresser put it: *"Our focus remains the same: making sure physicians, not investors, are the ones making medical decisions"*.

For now, the data is clear: the private equity machine is slowing down. And for many patients, physicians, and communities, that may be a very good thing.

---

## Disclaimer

*This article is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. The views expressed are based on publicly available data and reports as of August 2026. Market conditions, regulatory landscapes, and deal activity are subject to change. The author does not endorse any specific investment strategies or policy positions. Before making any financial or investment decisions based on the content of this article, please consult with qualified professionals who can evaluate your specific situation.*